Bevacizumab for Central Retinal Vein Occlusion Study

Summary

Central retinal vein occlusion is a leading cause of severe visual impairment. Until now, no treatment has been available to improve visual acuity. The present study intends to investigate if intravitreal bevacizumab can improve visual acuity as compared to sham-treated control patients.

Timeline

Start

2009-05

Primary completion

2011-03

Completion

2011-09

Drugs

Indications